Biolife Solutions (BLFS) Non-Current Deffered Revenue (2010 - 2021)
Biolife Solutions' (BLFS) quarterly Non-Current Deffered Revenue came in at $64000.0 in Q1 2021, down 9.86% on a QoQ basis from $71000.0 in Q4 2020.
Biolife Solutions (BLFS) Non-Current Deffered Revenue (2010 - 2021) Analysis & Trends
Biolife Solutions (BLFS) has 11 years of Non-Current Deffered Revenue data on file, last reported at $64000.0 in Q1 2021.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $64000.0 in Q1 2021; TTM through Mar 2021 was $64000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $71000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q1 2021 stood at $64000.0, down from $71000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for BLFS reached as high as $656581.0 in Q3 2017 and fell as low as -$62984.0 in Q1 2017.
- Historically, Non-Current Deffered Revenue has averaged $257346.6 across 4 years, with a median of $349000.0 in 2018.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 2575.45% in 2017 and fell as far as 572.32% in 2017.
- Year by year, Non-Current Deffered Revenue stood at $492000.0 in 2017, then decreased by 29.07% to $349000.0 in 2018, then slumped by 79.66% to $71000.0 in 2020, then dropped by 9.86% to $64000.0 in 2021.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $64000.0 in Q1 2021, $71000.0 in Q4 2020, and $349000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 163.15 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Dec 31, 2018 | 349,000.00 |
| Sep 30, 2018 | 386,113.00 |
| Jun 30, 2018 | 422,828.00 |
| Dec 31, 2017 | 492,000.00 |
| Sep 30, 2017 | 656,581.00 |
| Jun 30, 2017 | -62,419.00 |
| Mar 31, 2017 | -62,984.00 |
| Dec 31, 2016 | 27,989.00 |
| Sep 30, 2016 | 24,541.00 |
| Jun 30, 2016 | 19,929.00 |
| Mar 31, 2016 | 13,335.00 |
| Dec 31, 2015 | 914,674.00 |
| Sep 30, 2015 | 29,700.00 |
| Jun 30, 2015 | 21,651.00 |
| Mar 31, 2015 | 4,966.00 |
| Dec 31, 2014 | 874,825.00 |
| Sep 30, 2014 | -18,007.00 |
| Mar 31, 2014 | -5,227.00 |